Pasundan Arabica (Coffea arabica)

Pasundan Arabica is a traditional Coffea arabica cultivar from West Java, Indonesia, containing caffeine and chlorogenic acids as its primary bioactive compounds. These compounds interact with adenosine receptors and inhibit catechol-O-methyltransferase (COMT) to modulate alertness and antioxidant activity, though no cultivar-specific human trials exist.

Origin & History

Pasundan Arabica is a cultivar variant of Coffea arabica named after the Pasundan region in West Java, Indonesia, likely descended from Ethiopian selections introduced by the Dutch in the early 20th century for leaf rust resistance. The beans are harvested from the plant's cherries, dried, hulled, and roasted through standard coffee processing methods. This cultivar was bred specifically for adaptation to Indonesian highlands and belongs to the xanthine alkaloid chemical class.

Historical & Cultural Context

Pasundan Arabica has no documented historical use in traditional medicine systems, as it is a modern 20th-century selection from Indonesian breeding programs. While Coffea arabica originated in Ethiopian forests over 1,000 years ago and spread to Yemen by the 15th century for social use as an energizing beverage, the Pasundan cultivar itself lacks traditional medicinal applications.

Health Benefits

• No clinical evidence available - no human trials have been conducted on Pasundan Arabica specifically
• General Coffea arabica effects may apply but are not verified for this cultivar
• Potential caffeine-related benefits (alertness, metabolism) remain unstudied for Pasundan
• Possible antioxidant effects from chlorogenic acids are theoretical only
• No cultivar-specific health benefits have been documented in scientific literature

How It Works

Caffeine in Pasundan Arabica competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing inhibitory neurotransmission and increasing dopamine and norepinephrine signaling. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit glucose-6-phosphatase and slow intestinal glucose absorption, contributing to potential glycemic modulation. These same polyphenols scavenge reactive oxygen species and upregulate Nrf2-mediated antioxidant gene expression, though these pathways have not been specifically validated for the Pasundan cultivar.

Scientific Research

No clinical trials, RCTs, or meta-analyses specifically on Pasundan Arabica were identified in PubMed or other scientific databases. While broader Coffea arabica studies examine caffeine effects on cognition and metabolism, none differentiate or include the Pasundan cultivar. No PMIDs are available due to the complete absence of cultivar-specific human studies.

Clinical Summary

No human clinical trials have been conducted specifically on Pasundan Arabica as a distinct cultivar, making direct evidence-based claims impossible. General Coffea arabica research, including meta-analyses covering thousands of participants, supports cognitive enhancement and modest metabolic benefits attributable to caffeine (doses of 75–300 mg) and chlorogenic acids. A 2019 systematic review of green coffee extracts standardized to chlorogenic acids found modest reductions in fasting blood glucose and body weight, but these findings cannot be extrapolated to Pasundan without cultivar-specific phytochemical profiling. The evidence base for this specific cultivar remains at the preliminary, preclinical level.

Nutritional Profile

Pasundan Arabica (Coffea arabica) nutritional composition is based on general Arabica coffee bean data, as cultivar-specific analysis is not publicly available. Raw green coffee beans (per 100g): protein 11-13g (containing essential amino acids including glutamic acid ~2.3g, aspartic acid ~1.1g), total carbohydrates 38-45g (including sucrose ~6-9g as dominant sugar, reducing sugars <1g), dietary fiber 33-40g (primarily insoluble, including cellulose, hemicellulose, and galactomannans), total fat 15-17g (dominated by diterpenes cafestol and kahweol ~0.5-1.0g per 100g, linoleic acid as primary fatty acid ~60% of lipid fraction). Bioactive compounds: chlorogenic acids (CGAs) 6-12g per 100g green bean, primarily 5-caffeoylquinic acid (5-CQA) as dominant isomer; caffeine 1.2-1.5g per 100g (lower than Robusta). Trigonelline 0.6-1.2g per 100g, serving as niacin precursor upon roasting. Brewed coffee (per 240ml cup, assuming medium roast): caffeine 80-120mg, chlorogenic acids 70-200mg (significantly reduced by roasting degree), niacin (from trigonelline degradation) 0.5-1.0mg, potassium 116mg, magnesium 7mg, riboflavin (B2) 0.2mg. Roasting substantially degrades CGAs (up to 95% loss at dark roast) while generating melanoidins (antioxidant polymers) and pyrazines. Bioavailability: CGAs show 30-67% absorption in small intestine; colonic microbiota further metabolize remainder into dihydrocaffeic and dihydroferulic acids. Diterpenes cafestol and kahweol are largely retained in paper-filtered preparations at negligible levels but concentrated in unfiltered (French press, espresso) preparations. Pasundan-specific micronutrient or bioactive deviations from these general Arabica values are undocumented in published literature.

Preparation & Dosage

No clinically studied dosage ranges exist for Pasundan Arabica in any form (extract, powder, or standardized). General coffee consumption guidelines of 3-5 cups daily (200-400mg caffeine) apply to Coffea arabica broadly but have not been validated for this specific cultivar. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients documented, general coffee pairs with L-theanine, green tea, guarana

Safety & Interactions

Pasundan Arabica shares the safety profile of Coffea arabica, with caffeine content posing risks of anxiety, insomnia, tachycardia, and hypertension at doses exceeding 400 mg per day in healthy adults. Caffeine inhibits CYP1A2 enzyme activity and can elevate plasma levels of medications including clozapine, theophylline, and certain antidepressants, necessitating caution in polypharmacy patients. Chlorogenic acids may potentiate the hypoglycemic effects of metformin and insulin, increasing the risk of hypoglycemia. Pregnant individuals are advised to limit caffeine intake to under 200 mg per day, and individuals with cardiac arrhythmias or severe anxiety disorders should consult a physician before consumption.